grepafloxacin has been researched along with pd 131628 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, SD; Barry, AL; Fuchs, PC; Jorgensen, JH; Sewell, DL; Tenover, F | 1 |
| Allen, SD; Barry, AL; Fuchs, PC; Murray, PR; Sewell, DL; Tenover, FC | 1 |
2 other study(ies) available for grepafloxacin and pd 131628
| Article | Year |
|---|---|
Tentative criteria for determining the in vitro susceptibilities of Haemophilus influenzae, including quality control parameters, to two fluoroquinolones (grepafloxacin and PD 131628).
Topics: Anti-Infective Agents; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Naphthyridines; Piperazines; Quality Control; Quinolones | 1995 |
Tentative interpretive criteria and quality control parameters for in-vitro susceptibility testing of Neisseria gonorrhoeae to two fluoroquinolones (PD 131628 and grepafloxacin (OPC 17116)).
Topics: Anti-Infective Agents; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Neisseria gonorrhoeae; Piperazines; Quality Control; Quinolones | 1996 |